Travatan (Travoprost)

Travoprost is an eye drop medicine used to treat glaucoma. Glaucoma is a condition that damages the optic nerve, often due to high pressure inside the eye. Travoprost helps lower this pressure.

Brand names:Travatan, Travatan Z
Medication

What people taking Travatan (Travoprost) report

Every report comes from a Lived member, sent anonymously.

Have you tried Travatan (Travoprost) for Glaucoma?

NameHow it went

About Travatan (Travoprost)

What It's For

Travoprost is a prescription medicine that lowers the pressure inside the eye. It is used for open-angle glaucoma, the most common form of glaucoma, in which the optic nerve (the nerve that carries signals from the eye to the brain) is gradually damaged, and for ocular hypertension, in which eye pressure is higher than normal but the nerve has not yet been harmed. Lowering eye pressure is the main way to slow glaucoma and protect the vision a person still has. Most people use travoprost as eye drops. Travatan Z is the current brand of travoprost 0.004% drops, and generic travoprost drops are also available; the original Travatan formulation is no longer sold in the US. Travoprost also comes as iDose TR, a tiny implant that an eye surgeon places inside the eye, where it releases the medicine without daily drops. Travoprost belongs to a group of glaucoma medicines called prostaglandin analogs, which also includes latanoprost (Xalatan) and bimatoprost (Lumigan).

How It Works

The front of the eye is filled with a clear fluid called aqueous humor. The eye makes this fluid continuously, and an equal amount normally drains out. When drainage falls behind, pressure builds up and can strain the optic nerve. Travoprost is a man-made version of a prostaglandin, a natural signaling substance, and it activates the same receptor in eye tissue. This is thought to open up a second drainage route for the fluid (called uveoscleral outflow), so fluid leaves the eye more easily and pressure falls. Researchers do not fully understand every step of how it works. Eye pressure is measured in millimeters of mercury (mmHg) with a quick, painless test called tonometry. There is no single safe number for everyone: the amount of pressure an optic nerve can tolerate differs from person to person, so the eye doctor uses repeated exams of the nerve and vision to decide what pressure is right for each patient.

Dosage & Administration

For the drops, the usual dose is one drop in each affected eye once a day, in the evening. Using travoprost more than once a day does not add benefit and can actually weaken its pressure-lowering effect. Pressure starts to fall about 2 hours after a dose and reaches its lowest point about 12 hours later. Keep the dropper tip from touching the eye, eyelid, fingers or any other surface, because contaminated drops can cause a serious eye infection. Remove contact lenses before putting in the drop and wait 15 minutes before putting them back in. If you use more than one kind of eye drop, space them at least 5 minutes apart. The iDose TR implant is not used at home. An eye surgeon inserts it under anesthesia (numbing drops or an injection, or general anesthesia) through a small incision at the edge of the cornea, the clear front window of the eye, and anchors it in the eye's drainage area, where it slowly releases its 75 micrograms of travoprost. It is not replaced more than once a year. Before a first or repeat implant, the surgeon measures the cells lining the inside of the cornea, because the procedure can reduce them.

Side Effects

Eye redness is the most common side effect, reported by roughly a third to half of people in clinical trials. It is often tolerable, though up to 3% of trial participants stopped treatment because of it. Other common effects include eye discomfort, a feeling that something is in the eye, itching, eye pain and blurred or reduced vision. Travoprost can also change how the eye area looks. The colored part of the eye (the iris) can gradually become more brown, a change that may take months to years to notice and is likely permanent even after stopping. Eyelid skin can darken, and lashes in the treated eye can grow longer, thicker and more numerous; these changes often fade after stopping. Some people notice a deepening of the crease above the eyelid. When only one eye is treated, the two eyes can end up looking different. Less commonly, travoprost can cause swelling in the macula, the central part of the retina used for sharp vision, or flare up existing inflammation inside the eye. After an iDose TR implant, the most common problems in trials were a rise in eye pressure, inflammation of the iris (iritis), dry eye and changes on visual field testing. Infection inside the eye (endophthalmitis) is a rare but serious risk of any procedure inside the eye. If the implanted eye becomes red, painful or sensitive to light, or your vision changes, contact your eye surgeon right away to be seen that day.

Interactions & Warnings

Before starting, tell the eye doctor about other medicines, supplements and vitamins you take, including other eye drops. If you develop an eye infection or injury while using travoprost drops, or are scheduled for eye surgery, ask the prescriber promptly whether to keep using them. Travoprost is used with caution in people with active inflammation inside the eye (uveitis) and in those at higher risk of macular swelling, such as people who have had cataract surgery with a torn lens capsule or no replacement lens. It has not been studied for angle-closure, inflammatory or neovascular glaucoma, which are less common types that behave differently from open-angle glaucoma. There are no adequate studies in pregnant women. In animal studies, travoprost caused pregnancy loss and early delivery at doses that could be relevant to people, so it is used in pregnancy only when the benefit justifies the possible risk to the baby. Anyone pregnant or planning a pregnancy should discuss this with the eye doctor. It is not known whether travoprost passes into breast milk. The drops are not recommended for children under 16 because of concern about pigment changes with long-term use. The implant has its own limits. It is not used in an eye with an active or suspected infection, in people with a disease of the cornea's inner cell layer such as Fuchs dystrophy, or after a corneal transplant, and it is used with caution in eyes with a narrow drainage angle. It is safe in a magnetic resonance imaging (MRI) scanner only under specific conditions, so tell imaging staff about the implant and show the patient ID card that comes with it.

What to Expect

Eye pressure begins to fall within hours, but you will not feel the medicine working. Glaucoma drops do not improve vision or make the eyes feel different; they help keep vision from getting worse. At follow-up visits, the eye doctor rechecks pressure and examines the optic nerve and visual field to judge whether travoprost alone is enough or another medicine, laser treatment or surgery should be added. Glaucoma treatment is usually long-term. As long as travoprost is controlling pressure, it is typically used every day, and not using it as prescribed can lead to vision loss. Pigment and eyelash changes develop slowly, so it is reasonable to mention any change you notice at a routine visit. With the implant, there is no daily drop to remember. In two trials of people whose eye pressure averaged 24 mmHg, the implant lowered it by about 6.6 to 8.4 mmHg over the first three months, similar to twice-daily timolol drops (a beta-blocker eye drop). Over the following nine months it did not keep pace with timolol, so regular pressure checks remain important, and visits also confirm the implant is still in place.

Questions to Ask Your Doctor

  1. 1.Are drops or the iDose TR implant a better fit for me, and what would the implant procedure and follow-up involve?
  2. 2.What eye pressure are we aiming for, and how will we know whether travoprost is protecting my optic nerve?
  3. 3.How likely is a visible change in my eye color or eyelashes, especially if only one eye is treated?
  4. 4.If redness or irritation bothers me, what other options do I have?
  5. 5.Should anything change if I become pregnant, plan a pregnancy or am breastfeeding?

Last reviewed • Oct 2026

Educational content, not medical advice.